Loading organizations...
The GHS Fund is a Geneva-based nonprofit association that channels impact investment into global health security innovation. It functions as an innovation ecosystem, actively identifying and scaling equitable solutions designed to enhance global preparedness and response capabilities for health threats. The organization brings together traditional philanthropy with strategic investment to foster advancements in critical health security technologies and approaches.
Andrew and Lisa McDonald established the GHS Fund in 2021, selecting Geneva as its headquarters due to the city’s international profile and collaborative environment. Their founding insight centered on the critical need for dedicated financial mechanisms and an integrated ecosystem to accelerate the development and deployment of innovative solutions against global health challenges. This approach leverages impact investment principles to drive both social good and sustainable progress.
The GHS Fund serves a diverse network of innovators, entrepreneurs, and organizations committed to advancing global health security. Its vision is to cultivate a robust and resilient global health architecture by continuously fostering groundbreaking advancements. By strategically investing in and nurturing promising innovations, the GHS Fund aims to build a world better equipped to anticipate, prevent, detect, and respond to future health crises effectively.
GHS Fund has 2 tracked investments across 2 companies. The latest tracked deal is $98.0M Wave - Series C in V-Wave in December 2021.
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Dec 1, 2021 | V-Wave | $98.0M Wave - Series C | Deerfield Management | Aperture Venture Partners, BRM Group, Endeavour Vision, Israel Secondary Fund, Johnson & Johnson Innovation, Pontifax, Pura Vida Investments, Triventures |
| May 1, 2020 | ARTMS | $19.0M Series A | Deerfield Management | — |